FTC Shouldn't Try To Protect Consumers In Foreign Countries
Law360 (March 13, 2020, 6:01 PM EDT) -- On March 4, the Federal Trade Commission announced a settlement with a company over alleged deceptive advertising for a pain relief device. The settlement order was, in many ways, unremarkable and business as usual for the FTC.
For instance, similar to almost all other FTC orders from recent years on health-related advertising, the order imposes clinical testing requirements for certain future claims and extensive record-keeping around clinical studies. The unusual and particularly troubling part of this settlement is the expansive reach of the monetary relief it imposes — specifically, requiring that the company hand over substantial gains from sales to consumers...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!